<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01389531</url>
  </required_header>
  <id_info>
    <org_study_id>ORTESE 10-0515</org_study_id>
    <secondary_id>ORTESE HCPA-1</secondary_id>
    <nct_id>NCT01389531</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety Evaluation of HCPA-1 Silicone Stent in the Treatment of Central Airway Obstructions</brief_title>
  <official_title>Evaluation of the Efficacy and Safety of the HCPA-1 Silicone Stent in the Treatment of Central Airway Obstructions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is, primarily, evaluate the safety of the use of the silicone stent
      HCPA-1 in patients with clinically significant tracheal and/or bronchial stenosis.
      Secondarily, this study aims to evaluate the efficacy of the use of the silicone stent HCPA-1
      who are in the same conditions described above and also estimate the costs the use of these
      silicone stents involve.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  It is a prospective multicenter clinical study, not controlled, with evaluation of
           clinical variables before and after the intervention (insertion of one or more silicone
           stents in the trachea or bronchi and main or intermediate bronchus by rigid bronchoscopy
           under general anesthesia).

        -  110 patients, both genders, will be followed for one year, total of 8 visits, in order
           to evaluate the safety of the procedure of stent insertion.

      It is allowed to include patients for whom it is indicated the combination of treatments (eg,
      electrocoagulation followed by stent placement) - full anticoagulation or severe disturbance
      of coagulation. (Includes: use of any anticoagulant, by oral, intravenous or subcutaneous
      administration with full intention of coagulation / therapy; coagulopathy with INR&gt; 2.0 or
      aPTT [KTTP]&gt; 1.5 times control or platelet count &lt;50000). Note: The use of antiplatelet drugs
      (aspirin, clopidogrel, ticlopidine) is allowed.

      - The HCPA-1 silicone stent is made of biocompatible silicone, medical grade, via injection
      process in the matrix using different densities of the same material for a set of prostheses
      with rigid and flexible variables; available in the following dimensions (diameter x length
      in mm): 9x30, 9x50, 11x30, 11x50, 13x30, 13x50, 14x30, 14x50, 16x50, 16x70, 18x50 and 18x70.
      Requires specific surgical (applicator) for insertion.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with adverse events as a measurement of Safety</measure>
    <time_frame>1 year</time_frame>
    <description>three main adverse events will be followed:
migration of the stent;
granuloma formation;
accumulation of secretion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in Dyspnea using a Dyspnea score as a measurement of Efficacy</measure>
    <time_frame>1 year</time_frame>
    <description>MMRC dyspnea score will be used to measure the improvement of the patient's respiratory condition</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Tracheobronchomalacia</condition>
  <arm_group>
    <arm_group_label>Stents</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All recruited patients will be receiving a stent during a rigid bronchoscopy procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rigid bronchoscopy</intervention_name>
    <description>The HCPA-1 silicone stent available in the following dimensions (diameter x length in mm): 9x30, 9x50, 11x30, 11x50, 13x30, 13x50, 14x30, 14x50, 16x50, 16x70, 18x50 and 18x70 will be inserted through rigid bronchoscopy in patients who presented the criteria to participate in the study.</description>
    <arm_group_label>Stents</arm_group_label>
    <other_name>stents</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consent to participate in the study by signing (the patient or family member/ legal
             guardian) of the Informed Consent Form;

          -  18 years old or more;

          -  clinically significant stenosis (symptomatic or about to become symptomatic) for the
             trachea, main bronchus or intermediate bronchus, which can be treated with the stent
             implement.

        Exclusion Criteria:

          -  clinical or absolute anesthesic contraindication of the rigid bronchoscopy under
             general anesthesia;

          -  constitutional or acquired anatomic limitations that prevent the rigid bronchoscopy;

          -  another indication of exclusive preferential treatment modality for stenosis (surgery,
             radiotherapy, chemotherapy, other). Note: It is allowed to include patients for whom
             it is indicated the combination of treatments (eg, electrocoagulation followed by
             stent placement);

          -  full anticoagulation or severe disturbance of coagulation. (Includes: use of any
             anticoagulant, by oral, intravenous or subcutaneous administration with full intention
             of coagulation / therapy; coagulopathy with INR&gt; 2.0 or aPTT [KTTP]&gt; 1.5 times control
             or platelet count &lt;50000). Note: The use of antiplatelet drugs (aspirin, clopidogrel,
             ticlopidine) is permitted.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amarilio V Macedo, Postdoc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Clinicas de Porto Alegre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rosane P Schlatter, Master</last_name>
    <phone>555133597872</phone>
    <email>rschlatter@hcpa.ufrgs.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Getulio Vargas</name>
      <address>
        <city>Manaus</city>
        <state>Amazonas</state>
        <zip>69010130</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando L Westphal, Postdoc</last_name>
      <phone>55 92 3621 6500</phone>
      <email>f.l.westphal@uol.com.br</email>
    </contact>
    <investigator>
      <last_name>Fernando L Westphal, Doctorate</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Brasilia</name>
      <address>
        <city>Brasilia</city>
        <state>Distrito Federal</state>
        <zip>70840901</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuno F Lima, Postdoc</last_name>
      <phone>55 61 9983 6304</phone>
      <email>nunolima@globo.com</email>
    </contact>
    <investigator>
      <last_name>Nuno F Lima, Doctorate</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital das Cl√≠nicas de Goiania</name>
      <address>
        <city>Goiania</city>
        <state>Goias</state>
        <zip>74605020</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albino A Oliveira, MD</last_name>
      <phone>55 62 99710224</phone>
      <email>aalegro@terra.com.br</email>
    </contact>
    <investigator>
      <last_name>Albino A Oliveira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Antonio Pedro</name>
      <address>
        <city>Niteroi</city>
        <state>Rio de Janeiro</state>
        <zip>24322380</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luiz F Judice, Postdoc</last_name>
      <phone>55 21 9986 5267</phone>
      <email>lfjudice@urbi.com.br</email>
    </contact>
    <investigator>
      <last_name>Luiz F Judice, Doctorate</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro de Ciencias da Saude</name>
      <address>
        <city>Natal</city>
        <state>Rio Grande do Norte</state>
        <zip>59012300</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos A Araujo, Doc</last_name>
      <phone>55 84 3125 4290</phone>
      <email>cabeto@digi.com.br</email>
    </contact>
    <investigator>
      <last_name>Carlos A Araujo, Doctorate</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HCPA Hospital de Clinicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <zip>900350903</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amarilio V Macedo, `Postdoc</last_name>
      <phone>55 51 3359 8911</phone>
      <email>aneto@hcpa.ufrgs.br</email>
    </contact>
    <contact_backup>
      <last_name>Rosane P Schlatter, Ms</last_name>
      <phone>55 51 3359 7872</phone>
      <email>rschlatter@hcpa.ufrgs.br</email>
    </contact_backup>
    <investigator>
      <last_name>Amarilio V Macedo, Postdoc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital do Cancer I</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>20230130</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauro M Zamboni, Postdoc</last_name>
      <phone>55 2506 6185</phone>
      <email>mauro.zamboni@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mauro M Zamboni, Ms</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04024002</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iunis Suzuki, Postdoc</last_name>
      <phone>55 11 8259 9455</phone>
      <email>iunis.suzuki@terra.com.br</email>
    </contact>
    <investigator>
      <last_name>Iunis Suzuki, Doctorate</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helio Minamoto, Postdoc</last_name>
      <phone>55 11 9977 5745</phone>
      <email>minamoto@usp.br</email>
    </contact>
    <investigator>
      <last_name>Helio Minamoto, Doctorate</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Saueressig MG, Sanches PR, Macedo Neto AV, Moreschi AH, Oliveira HG, Xavier RG. Novel silicone stent to treat tracheobronchial lesions: results of 35 patients. Asian Cardiovasc Thorac Ann. 2010 Dec;18(6):521-8. doi: 10.1177/0218492310388428.</citation>
    <PMID>21149399</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2011</study_first_submitted>
  <study_first_submitted_qc>July 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2011</study_first_posted>
  <last_update_submitted>December 30, 2014</last_update_submitted>
  <last_update_submitted_qc>December 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Airway Obstruction</mesh_term>
    <mesh_term>Tracheobronchomalacia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

